March 24, 2011 (Edmonton and Calgary, Alberta) — In clinical practice and as has been seen in clinical trials, combining an angiotensin-converting enzyme (ACE) inhibitor with an angiotensin-receptor ...
Monotherapy was more effective in preserving renal function. In patients with baseline nephropathy, angiotensin-converting-enzyme inhibitors and angiotensin-receptor blockers (ARBs) reduce proteinuria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback